- 期刊
Genetically Engineered Islets and Alternative Sources of Insulin-Producing Cells for Treating Autoimmune Diabetes: Quo Vadis?
延伸閱讀
- 劉慧俐、洪信嘉、韓永光、林英助、葉錦瑩（2016）。Family Diabetic History as an Important Factor of Raising the Screening Efficiency of Prediabetes with Impaired Fasting Glucose。台灣老年醫學暨老年學雜誌，11(3)，169-185。https://doi.org/10.29461/TGG.201608_11(3).0003
- Messier, C., & Teutenberg, K. (2005). The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease. Neural Plasticity, 2005(), 311-328. https://doi.org/10.1155/NP.2005.311
- 鄭淑妃、周美惠、林明芳（2001）。The Development and Clinical Use of Insulin。榮總護理，18(1)，8-14。https://doi.org/10.6142/VGHN.18.1.8
- 蔡崇煌、王雪芳、林綺詩、鄭正業、賴淑娥、王俊堯（2013）。Latent Autoimmune Diabetes in Adults: Type 1.5 Diabetes Mellitus。臺灣營養學會雜誌，38(1)，11-18。https://doi.org/10.6691/NSJ.201303_38(1).0002
- Muscogiuri, G., Palomba, S., Laganà, A. S., & Orio, F. (2016). Inositols in the Treatment of Insulin-Mediated Diseases. International Journal of Endocrinology, 2016(), 366-381-041. https://doi.org/10.1155/2016/3058393